Drawing for COMPLETE GENOMICS

USPTO serial 98032973

COMPLETE GENOMICS

Reviewed by CopyMark Law Group

Status 748
Filing date
Status date
Registration date
Examiner
MOSCATI, JUSTIN RONALD
Law office
TMO LAW OFFICE 127

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with COMPLETE GENOMICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

R. Gwen Peterson

R. Gwen Peterson KILPATRICK TOWNSEND & STOCKTON LLP2175 NORTH CALIFORNIA BOULEVARDSUITE 600WALNUT CREEK, CA 94596

Goods and services

ClassDescriptionStatusFirst use
001Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; Chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; Diagnostic reagents and preparations, except for medical or veterinary use; Chemical reagents, other than for medical or veterinary purposes; Biological preparations, other than for medical or veterinary purposes, namely, for use in industry and science; Biochemical preparations for scientific purposes; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposesACTIVEDec 29, 2023
005Preparations for detecting genetic predispositions for medical purposes; reagents for use in medical genetic testing. Enzyme preparations for medical purposes; Chemical pharmaceutical preparations for detecting genetic predispositions; Chemical reagents for medical or veterinary purposesACTIVEDec 29, 2023
009Analyzers for genome information, namely, laboratory devices for detecting genetic sequences, and recorded computer programs for scientific analysis of genetic sequences; nucleic acid sequencer for scientific purposes; gene amplification instrument for scientific purposes; DNA chips; diagnostic apparatus for the detection of pathogens for laboratory or research use; Recorded computer programs for biological data mining; Recorded computer programs for developing bioinformatics database for others; data processing apparatus; bio-chips for research or scientific purposesACTIVEDec 29, 2023
010Medical apparatus and instruments for detecting tumor cancer and genetic diseases; diagnostic testing apparatus for testing samples of body fluid, tissue and organ for medical use; diagnostic apparatus for the detection of cancer; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; medical apparatus and instruments for detecting and treating tumor and cancer; nucleic acid purification reagent kits comprised primarily of probes, buffers, and reagents for medical purposes; genome machine for medical purposes, namely, genetic sequencer for medical diagnostic purposes.ACTIVEDec 29, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 30, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE
Apr 13, 2026IUAFUSE AMENDMENT FILED
Apr 13, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 29, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 29, 2026EX3GSOU EXTENSION 3 GRANTED
Jan 28, 2026EXT3SOU EXTENSION 3 FILED
Jan 28, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 24, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 23, 2025EX2GSOU EXTENSION 2 GRANTED
Jul 23, 2025EXT2SOU EXTENSION 2 FILED
Jul 23, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 31, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 31, 2025EX1GSOU EXTENSION 1 GRANTED
Jan 31, 2025EXT1SOU EXTENSION 1 FILED
Jan 30, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 4, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 4, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 30, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 30, 2024XAECEXAMINER'S AMENDMENT ENTERED
Apr 30, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 30, 2024GNEAEXAMINERS AMENDMENT E-MAILED
Apr 30, 2024CNEAEXAMINERS AMENDMENT -WRITTEN
Apr 23, 2024ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 26, 2024PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 11, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 8, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 8, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 5, 2024GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Mar 5, 2024GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Mar 5, 2024CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 29, 2024DOCKASSIGNED TO EXAMINER
Jul 13, 2023MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 12, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2023NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance